Zhou, Zi-Ying, Han, Xiao-Yang, Sun, Lian-Qi, Li, Si-Yan, Xue, Si-Tu, Li, Zhuo-Rong (2022) Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer. Frontiers in Chemistry, 10. doi:10.3389/fchem.2022.1058256
Reference Type | Journal (article/letter/editorial) | ||
---|---|---|---|
Title | Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer | ||
Journal | Frontiers in Chemistry | ||
Authors | Zhou, Zi-Ying | Author | |
Han, Xiao-Yang | Author | ||
Sun, Lian-Qi | Author | ||
Li, Si-Yan | Author | ||
Xue, Si-Tu | Author | ||
Li, Zhuo-Rong | Author | ||
Year | 2022 (November 24) | Volume | 10 |
Publisher | Frontiers Media SA | ||
DOI | doi:10.3389/fchem.2022.1058256Search in ResearchGate | ||
Generate Citation Formats | |||
Mindat Ref. ID | 15665093 | Long-form Identifier | mindat:1:5:15665093:1 |
GUID | 0 | ||
Full Reference | Zhou, Zi-Ying, Han, Xiao-Yang, Sun, Lian-Qi, Li, Si-Yan, Xue, Si-Tu, Li, Zhuo-Rong (2022) Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer. Frontiers in Chemistry, 10. doi:10.3389/fchem.2022.1058256 | ||
Plain Text | Zhou, Zi-Ying, Han, Xiao-Yang, Sun, Lian-Qi, Li, Si-Yan, Xue, Si-Tu, Li, Zhuo-Rong (2022) Structure-based virtual screening identified novel FOXM1 inhibitors as the lead compounds for ovarian cancer. Frontiers in Chemistry, 10. doi:10.3389/fchem.2022.1058256 | ||
In | (2022) Frontiers in Chemistry Vol. 10. Frontiers Media SA |
See Also
These are possibly similar items as determined by title/reference text matching only.